Ciprofibrate is a fibric-acid derivative PPAR-alpha activator that lowers plasma triglycerides and raises HDL cholesterol, used in dyslipidaemia management. Simson Pharma's Ciprofibrate reference standard and impurities support compendial testing for this lipid-lowering fibrate.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Ciprofibrate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.